Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Study investigators will examine the absorption characteristics of apixaban, a direct-acting
oral anticoagulation, in patients who have underwent a particular kind of surgery
(pancreaticoduodenectomy) which involves resection of the duodenum.